Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8771126 | 1.00 | TSHR (0.57) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| SCHEMBL154641 | 0.98 | TSHR (0.54) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| SCHEMBL1871016 | 0.98 | TSHR (0.54) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| SCHEMBL1685294 | 0.93 | TSHR (0.51) | TSHRGPR84FFAR1TDP1 | |
| SCHEMBL6131095 | 0.91 | TSHR (0.47) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| Decylacetate SCHEMBL21837279 | 0.90 | TSHR (0.48) | TSHRGPR84FFAR1NAAAMAPT | |
| SCHEMBL5403623 | 0.88 | TSHR (0.49) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| SCHEMBL1081673 | 0.86 | TSHR (0.50) | TSHRGPR84FFAR1ZDHHC7ABCB1 | |
| SCHEMBL9323925 | 0.85 | TSHR (0.46) | TSHRGPR84FFAR1TDP1MAPT | |
| SCHEMBL22598182 | 0.84 | TSHR (0.59) | TSHRGPR84FFAR1ZDHHC7TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024073721-A1 | METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| US-11801323-B2 | Absorbent article with philic anhydrous lotion | THE PROCTER AND GAMBLE COMPANY (US) | 2023-10-31 | — | — | US | disclosed |
| US-20210236685-A1 | ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION | PROCTER & GAMBLE (US) | 2021-08-05 | — | — | US | disclosed |
| US-10912857-B2 | Absorbent article with philic anhydrous lotion | THE PROCTER & GAMBLE COMPANY (US) | 2021-02-09 | — | — | US | disclosed |
| US-20180050126-A1 | ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION | PROCTER & GAMBLE (US) | 2018-02-22 | — | — | US | disclosed |
| EP-2624870-B1 | ABSORBENT ARTICLE WITH LOTION | PROCTER & GAMBLE (US) | 2018-01-17 | — | — | EP | disclosed |
| US-9808551-B2 | Absorbent article with philic anhydrous lotion | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
| US-9669130-B2 | Absorbent article with lotion | THE PROCTER & GAMBLE COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| EP-2624807-B1 | ABSORBENT ARTICLE WITH ANHYDROUS LOTION | PROCTER & GAMBLE (US) | 2015-12-09 | — | — | EP | disclosed |
| US-9018345-B2 | Process for the preparation of polyetherester polyols | BASF SE (DE) | 2015-04-28 | — | — | US | disclosed |
| US-7135165-B2 | Multiphase sunscreen compositions | ALZO INTERNATIONAL, INC. (US) | 2006-11-14 | — | — | US | disclosed |
| CN-1174037-C | Gel composition | �����ɺϻ﹫˾ | 2004-11-03 | — | — | CN | disclosed |
| US-6749860-B2 | OUTER COVER, A LIQUID PERMEABLE BODYSIDE LINER WITH 50-95% OF AN EMOLLIENT, 1-40% OF A VISCOSITY ENHANCER AND .1-10% OF AN EXTRACTED ACTIVE BOTANICAL AND AN ABOSRBENT BODY BETWEEN; SKIN HEALTHY DIAPERS, ADULT INCONTINENCE PRODUCTS, ETC. | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-06-15 | — | — | US | disclosed |
| US-20040096404-A1 | Multiphase sunscreen compositions | ALZO INTERNATIONAL INC. | 2004-05-20 | — | — | US | disclosed |
| CN-1134418-C | Substituted pyrazolyl benzenesulfonamides for treating inflammation | - | 2004-01-14 | — | — | CN | disclosed |
| EP-1345632-A2 | ABSORBENT ARTICLES WITH NON-AQUEOUS COMPOSITIONS CONTAINING BOTANICALS | Kimberly-Clark Worldwide, Inc. (US) | 2003-09-24 | — | — | EP | disclosed |
| US-20020136755-A1 | Absorbent articles with non-aqueous compositions containing botanicals | KIMBERLY-CLARK WORLDWIDE, INC. | 2002-09-26 | — | — | US | disclosed |
| WO-2002051456-A2 | ABSORBENT ARTICLES WITH NON-AQUEOUS COMPOSITIONS CONTAINING BOTANICALS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2002-07-04 | — | — | WO | disclosed |
| US-5959130-A | OF CASTOR OIL, HYDROGENATED CASTOR OIL, RICINOLEIC ACID AND HYDROXY STEARIC ACID; DILUENTS, SOLVENTS, LOTIONS, SOLUBILIZERS, LIQUID CARRIERS, VEHICLES AND THE LIKE FOR COSMETICS AND TOILETRY FORMULATIONS | FINETEX, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| US-5013473-A | Encapsulated cosmetic materials and process of making | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210236685-A1 | ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION | CUTA, AQP1, SLC35B2 | TSHR 4465/4885GPR84 3734/4885FFAR1 2375/4885 |
| US-11801323-B2 | Absorbent article with philic anhydrous lotion | CUTA, AQP1, SLC35B2 | TSHR 4465/4885GPR84 3734/4885FFAR1 2375/4885 |
| US-10912857-B2 | Absorbent article with philic anhydrous lotion | CUTA, AQP1, SLC35B2 | TSHR 4465/4885GPR84 3734/4885FFAR1 2375/4885 |
| US-20180050126-A1 | ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION | CUTA, AQP1, SLC35B2 | TSHR 4465/4885GPR84 3734/4885FFAR1 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.